Exchange
Hypotheses
Top-ranked hypotheses by composite score. Filter by lifecycle status, disease, or target gene; sort by score or recency. Click a row to open evidence, scoring detail, and any live prediction markets referencing it.
3
total hypotheses
| # | Hypothesis | Target gene | Status | Composite | Updated | |
|---|---|---|---|---|---|---|
| 1 | CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delivery pharmacology 6 ev h-65a83ac920 | HDAC3 (class I histone deacetylase) | proposed | 0.620 | 2026-05-14 | Open → |
| 2 | Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition pharmacology 6 ev h-5c618b582c | HDAC6 (class IIb histone deacetylase) | proposed | 0.570 | 2026-05-14 | Open → |
| 3 | CX3CR1-Targeted AntimiR-155 Oligonucleotides for Microglial Priming Reversal pharmacology 10 ev h-c381434159 | MIR155 (microRNA-155) | proposed | 0.530 | 2026-05-14 | Open → |